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Tumor necrosis factor-α (TNF) can trigger apoptosis or necrosis in different cells,
therefore is widely used to study the signaling pathways of cell death. While
receptor-interacting protein 1 (RIP1) participates in both apoptosis and necrosis,
our recent studies have shown that RIP3 is essential for TNF-induced necroptosis
but has no role in TNF-induced apoptosis.
We attempt to obtain an overall picture of the death pathways through studying
TNF-induced cell death. The morphological and biochemical features are often
used to distinguish different types of cell death, but it is notable that certain
features of apoptosis can also be detected in necroptosis. We used the caspase
dependence to separate apoptosis and necroptosis, and determinated the
dependence of RIP1 and/or RIP3 in TNF-induced cell death in different
fibroblasts. We found that, although RIP1 and RIP3 participate in TNF-induced
cell death of fibroblasts, the role of RIP1 and RIP3 in different primary or
immortalized fibroblasts is not identical. In addition to RIP1-dependent apoptosis
and RIP3-dependent necroptosis, we also identified RIP1-independent apoptosis
and RIP1/RIP3-independent necroptosis. Although autophagy has been reported
to be associated with necroptosis, we concluded that it is not required for TNF-
induced necroptotic cell death in L929. Thus, TNF can signal multiple pathways to
induce apoptosis or necroptosis, and the predominant death pathway in different
cells or cell lines can be significantly diverse.
We have revealed that TNF-induced RIP3- and RIP1-dependent and independent
cell death pathways in different types of fibroblasts. Our research has shed new
light on the current understanding about TNF-induced cell death and helped to
further reveal the details of molecular mechanisms of apoptosis and necroptosis.
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